Circular Genomics Readying to Launch Zoloft Response Diagnostic Based on Circular RNA Biomarker

NEW YORK, NY., July 27, 2023 (GenomeWeb) -- Molecular diagnosticsstartup Circular Genomics has identified a new biomarker that can predict whichpatients are likely to respond to Pfizer's antidepressant Zoloft (Sertraline).